Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Irving

Showing results (91-100 of 195) with videos related to

Pageof 20
Sort By:
Inflammatory Bowel Diseases|February 8, 2026
Rapid symptomatic improvement with etrasimod in ulcerative colitis: a post-hoc analysis of the ELEVATE UC programMarla C Dubinsky, María Chaparro, Peter M Irving, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 16, 2024
Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trialStefan Schreiber, Geert D'Haens, Fraser Cummings, et al.
Advances in Therapy|January 19, 2026
Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-AnalysisStefan Schreiber, Silvio Danese, Jean-Frédéric Colombel, et al.
Inflammatory Bowel Diseases|June 28, 2020
Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient PerspectiveJennie N Clough, Katie L Hill, Alexa Duff, et al.
Journal of Crohn'S & Colitis|December 28, 2021
Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and TreatmentSailish Honap, Susanna Meade, Ashley Spencer, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 24, 2022
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort studyRaphael P Luber, Alexa Duff, Polychronis Pavlidis, et al.
BMJ Open|December 25, 2025
Effectiveness of etrasimod on disease activity and patient-reported outcomes in ulcerative colitis-EFFECT-UC: a non-interventional, multinational, prospective cohort study protocolGordon W Moran, Shellie J Radford, Alissa Walsh, et al.
United European Gastroenterology Journal|March 8, 2018
Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across EuropePetra Baji, László Gulácsi, Valentin Brodszky, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2022
Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutionsStefan Schreiber, Peter M Irving, Ala I Sharara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2020
Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel DiseasesKonstantinos Papamichael, William T Clarke, Niels Vande Casteele, et al.
Pageof 20

Showing results (91-100 of 195) with videos related to

Sort By:
Pageof 20
Inflammatory Bowel Diseases|February 8, 2026
Rapid symptomatic improvement with etrasimod in ulcerative colitis: a post-hoc analysis of the ELEVATE UC programMarla C Dubinsky, María Chaparro, Peter M Irving, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 16, 2024
Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trialStefan Schreiber, Geert D'Haens, Fraser Cummings, et al.
Advances in Therapy|January 19, 2026
Comparative Efficacy and Safety of Advanced Therapies in Maintenance Treatment of Adult Patients with Moderate-to-Severe Crohn's Disease: A Systematic Literature Review and Network Meta-AnalysisStefan Schreiber, Silvio Danese, Jean-Frédéric Colombel, et al.
Inflammatory Bowel Diseases|June 28, 2020
Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient PerspectiveJennie N Clough, Katie L Hill, Alexa Duff, et al.
Journal of Crohn'S & Colitis|December 28, 2021
Anogenital Crohn's Disease and Granulomatosis: A Systematic Review of Epidemiology, Clinical Manifestations, and TreatmentSailish Honap, Susanna Meade, Ashley Spencer, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 24, 2022
Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort studyRaphael P Luber, Alexa Duff, Polychronis Pavlidis, et al.
BMJ Open|December 25, 2025
Effectiveness of etrasimod on disease activity and patient-reported outcomes in ulcerative colitis-EFFECT-UC: a non-interventional, multinational, prospective cohort study protocolGordon W Moran, Shellie J Radford, Alissa Walsh, et al.
United European Gastroenterology Journal|March 8, 2018
Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across EuropePetra Baji, László Gulácsi, Valentin Brodszky, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2022
Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutionsStefan Schreiber, Peter M Irving, Ala I Sharara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2020
Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel DiseasesKonstantinos Papamichael, William T Clarke, Niels Vande Casteele, et al.
Pageof 20